investments in the trust account, we may, at any time (based on our management team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
Related Party Transactions
On July 31, 2024 our sponsor paid $25,000, or approximately $0.003 per share, to cover certain of our offering costs in exchange for 7,187,500 founder shares. Subsequently, our sponsor forfeited an aggregate of 1,437,500 founder shares, such that our sponsor owns an aggregate of 5,750,000 founder shares. Following and as a result of that forfeiture of founder shares, the sponsor is deemed to have purchased the founder shares for $0.004 per share.
The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units if the underwriter’s over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 750,000 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriter’s over-allotment is exercised. If we increase or decrease the size of the offering, we will effect a share capitalization or a share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares at 20% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement shares).
Our sponsor has committed to purchase an aggregate of 175,000 private placement units (including if the underwriter’s over-allotment option is exercised), at a price of $10.00 per unit, or $1,750,000 in the aggregate (including if the underwriter’s over-allotment option is exercised), in a private placement that will close simultaneously with the closing of this offering. The private placement units will also be worthless if we do not complete our initial business combination. The private placement units will be identical to the public units sold in this offering except that they will not include any contingent rights to receive distributable shares and, so long as they are held by our sponsor or its permitted transferees, (i) the private placement units may not (including the securities underlying the units), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination and (ii) the private placement shares underlying the private placement units will be entitled to registration rights.
Prior to or in connection with the completion of our initial business combination, there may be payment by the company to our sponsor, officers or directors, or our or their affiliates, of a finder’s fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the completion of our initial business combination, which, if made prior to the completion of our initial business combination, will be paid from net proceeds of this offering and the sale of the private placement units not held in the trust account.
Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates.
Prior to the closing of this offering, our sponsor may loan us funds in an aggregate amount of up to $300,000 to be used for a portion of the expenses of this offering. These loans would be non-interest bearing, unsecured and will be repaid either (i) out of the $750,000 of offering proceeds that has been allocated to the payment of offering expenses or (ii) from amounts available for working capital.
As of December 31, 2024, we had borrowed $127,615 under the promissory note with our sponsor.
We expect to fund our working capital requirements prior to the time of our initial business combination with net proceeds of this offering and the sale of the private placement units not held in the trust account. In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required on a non-interest basis. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use net proceeds of this offering and the sale of the private placement units not held in the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loan amounts. Up to $1,500,000 of such loans may be convertible into private placement shares of the post business combination entity at a price of $10.00 per 1.1 shares at the option of the lender. Such shares would be identical to the private placement shares. Except as set forth above, the terms of such loans,